Table of contents

Extended reports

• Histopathological prevalence of subchondral insufficiency fracture of the femoral head (25 May, 2007)

  T Yamamoto, Y Iwamoto, R Schneider, P G Bullough
• Treatment of lupus-prone NZB/NZW F₁ mice with recombinant soluble Fcγ receptor II (CD32)

  (8 June, 2007)

  S Werwitzke, D Trick, P Sondermann, K Kamino, B Schlegelberger, K Kniesch, A Tiede, U Jacob, R E Schmidt, T Witte
• Subintimal Ki-67 as a synovial tissue biomarker for inflammatory arthropathies (5 July, 2007)

  F Pessler, A Ogdie, C Diaz-Torne, L Dai, X Yu, E Einhorn, S Gay, H R Schumacher
• One-year follow-up of Coll2-1, Coll2-1NO₂ and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement

  (20 July, 2007)

  M Deberg, J-E Dubuc, A Labasse, C Sanchez, E Quettier, A Bosseloir, J-M Crielaard, Y Henrotin
• Intracellular localisation of galectin-3 has a protective role in chondrocyte survival (1 June, 2007)

  C Boileau, F Poirier, J-P Pelletier, M Guévremont, N Duval, J Martel-Pelletier, P Reboul
• The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy (29 August, 2007)

  D van der Heijde, G Burmester, J Melo-Gomes, C Codreanu, E Martin Mola, R Pedersen, B Freundlich, D J Chang, for the Etanercept Study 400 Investigators
• Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis (20 July, 2007) Free

  T Takeuchi, Y Tatsuki, Y Nogami, N Ishiguro, Y Tanaka, H Yamanaka, N Kamatani, M Harigai, J Ryu, K Inoue, H Kondo, S Inokuma, T Ochi, T Koike
• EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (15 May, 2007)

  G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, D Isenberg, C G M Kallenberg, M Khamashta, J C Piette, M Schneider, J Smolen, G Sturfelt, A Tincani, R van Vollenhoven, C Gordon, D T Boumpas
• The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston–Leeds Osteoarthritis Knee Score) (1 May, 2007)

  D J Hunter, G H Lo, D Gale, A J Grainger, A Guermazi, P G Conaghan
• High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study (25 May, 2007)

  S W Syversen, P I Gaarder, G L Goll, S Ødegård, E A Haavardsholm, P Mowinckel, D van der Heijde, R Landewé, T K Kvien
• Physical work and chronic shoulder disorder. Results of a prospective population-based study (25 May, 2007)

  H Miranda, L Punnett, E Viikari-Juntura, M Heliövaara, P Knekt
• Inverse relationship between vertebral fractures and spine osteoarthritis in postmenopausal women with osteoporosis (8 June, 2007)

  C Roux, J Fechtenbaum, K Briot, C Cropet, S Liu-Léage, C Marcelli
• Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk (8 June, 2007)

  H G Raterman, V P van Halm, A E Voskuyl, S Simsek, B A C Dijkmans, M T Nurmohamed
• Clinical, radiographic and functional differences between juvenile-onset and adult–onset ankylosing spondylitis: results from the PSOAS cohort (29 June, 2007)

  L S Gensler, M M Ward, J D Reveille, T J Learch, M H Weisman, J C Davis
• Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results (20 July, 2007)

  D Aletaha, V Strand, J S Smolen, M M Ward
• Characteristics and survival of 26 patients with paraneoplastic arthritis (29 June, 2007)

  J Morel, V Deschamps, E Toussirot, E Pertuiset, C Sordet, P Kieffer, J M Berthelot, H Champagne, X Mariette, B Combe
• Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis (2 July, 2007)

  B Faragó, L Magyari, E Sáfrány, V Csöngei, L Járomi, K Horvatovich, C Sipeky, A Maász, J Radics, Á Gyetvai, Z Szekanecz, L Czirják, B Melegh
• The PTPN22*C1858T functional polymorphism is associated with susceptibility to inflammatory polyarthritis but neither this nor other variants spanning the gene is associated with disease outcome (31 July, 2007)

  H Naseem, W Thomson, A Silman, J Worthington, D Symmons, A Barton
• Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis (29 June, 2007)

  K S S Steen, M T Nurmohamed, I Visman, M Heijerman, M Boers, B A C Dijkmans, W F Lems
• Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis (10 September, 2007)

  G Wells, T Li, L Maxwell, R Maclean, P Tugwell